Cargando…
Amantadine Treatment for People with COVID-19
SARS-Cov-2, whose symptoms include difficulty swallowing, coughing, diarrhea, and breathing failure, has caused the loss of many lives around the world. In the absence of a vaccine or medication to help prevent or decrease the effects of the disease, we suggest that amantadine may reduce the effects...
Autores principales: | Araújo, Ramiro, Aranda-Martínez, José Dolores, Aranda-Abreu, Gonzalo Emiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IMSS. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290190/ https://www.ncbi.nlm.nih.gov/pubmed/32571606 http://dx.doi.org/10.1016/j.arcmed.2020.06.009 |
Ejemplares similares
-
Response to: Amantadine, COVID-19 and Parkinsonism
por: Aranda-Abreu, Gonzalo Emiliano
Publicado: (2020) -
Observational study of people infected with SARS-Cov-2, treated with amantadine
por: Aranda-Abreu, Gonzalo Emiliano, et al.
Publicado: (2020) -
Amantadine as a drug to mitigate the effects of COVID-19
por: Aranda Abreu, Gonzalo Emiliano, et al.
Publicado: (2020) -
Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2
por: Cortés-Borra, Albert, et al.
Publicado: (2021) -
Amantadine, COVID-19 and Parkinsonism
por: Wiwanitkit, Viroj
Publicado: (2020)